QuidelOrtho Corporation (NASDAQ:QDEL) Q2 Earnings Conference Call August 4, 2022 5:00 PM ET

Company Participants

Bryan Brokmeier - Vice President, Investor Relations

Douglas Bryant - Chairman and CEO

Joseph Busky - CFO

Conference Call Participants

Jack Meehan - Nephron Research

Andrew Cooper - Raymond James

Casey Woodring - JP Morgan

Alex Nowak - Craig Hallum

Operator

Welcome to the QuidelOrtho’s Second Quarter 2022 Financial Results Conference Call and Webcast. At this time, all participants lines are in a listen-only mode. [Operator Instructions] Please note this conference is being recorded. An audio replay of the conference call will be available on the company’s website within a few hours after the call.

I would now like to turn the call over to Bryan Brokmeier, Vice President of Investor Relations. Please proceed.

Bryan Brokmeier

Thank you, operator. Good afternoon everyone, and welcome to the QuidelOrtho’s second quarter financial results conference call.

With me today to discuss our financial results are Douglas Bryant, QuidelOrtho’s Chairman and CEO; and Joe Busky, QuidelOrtho’s Chief Financial Officer. This conference call is being simultaneously webcast on the investors section of our website and a version of today’s presentation can be downloaded there.

Before we begin, I will cover our safe harbor statement. Some of the statements we will make during this call about the company’s future expectations, plans and prospects constitute forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, which provides a safe harbor for such statements.

Our use of forward-looking statements is subject to a number of risks, uncertainties and other factors that could cause actual results to differ materially from our current expectations. These risks and uncertainties include, but are not limited to, those factors identified in the joint proxy statement prospectus are quarterly report on Form 10-Q that we plan to file tomorrow and our other filings with the SEC.

Please refer to our SEC filings for a more detailed discussion of forward-looking statements and the risks and uncertainties of such statements. We cannot assure you that the forward-looking statements we make or filed will be realized. Furthermore this conference call contains time sensitive information that’s accurate only as of today. Except as required by law, we undertake no obligation to update any forward-looking statement or time sensitive information to reflect future events, developments or changed circumstances or for any other reason.

Also during today’s call, to facilitate a comparison of the company’s operating performance in the second quarter of 2021 to second quarter of 2022, we will be discussing supplemental second quarter 2022 and 2021 revenues and adjusted operating results as Quidel and Ortho has been combined for the [Indiscernible] period. We will refer to this information as our supplemental combined information. This supplemental combined information as well as certain other items, we will discuss do not conform to U.S. Generally Accepted Accounting Principles, or GAAP. Please see slide three for a list of non-GAAP measures.